Antigen News and Research

RSS
Unlocking tumor immune evasion: IL1RL1+ Treg cells and CAFs collaborate for immunotherapy resistance

Unlocking tumor immune evasion: IL1RL1+ Treg cells and CAFs collaborate for immunotherapy resistance

West Nile virus surges to highest incidence since 2012

West Nile virus surges to highest incidence since 2012

Study finds that germline-encoded specificities cannot always predict the trajectory of B-cell responses

Study finds that germline-encoded specificities cannot always predict the trajectory of B-cell responses

Study unveils previously unknown urinary biomarkers, revolutionizing early detection and treatment of viral infections like COVID-19

Study unveils previously unknown urinary biomarkers, revolutionizing early detection and treatment of viral infections like COVID-19

Study challenges the use of biochemical recurrence as prostate cancer predictor

Study challenges the use of biochemical recurrence as prostate cancer predictor

Insights into COVID-19's aftermath: 2-year study examines lasting health effects

Insights into COVID-19's aftermath: 2-year study examines lasting health effects

Study finds that MRI is more sensitive than PSA test for detecting prostate cancer

Study finds that MRI is more sensitive than PSA test for detecting prostate cancer

Researchers develop new, modular strategy for T-cell-based immunotherapy

Researchers develop new, modular strategy for T-cell-based immunotherapy

Study shows that CD98hc can be targeted to deliver biotherapeutics in brain

Study shows that CD98hc can be targeted to deliver biotherapeutics in brain

New kidney tissue model could help assess safety of immunotherapy drugs

New kidney tissue model could help assess safety of immunotherapy drugs

Artificial intelligence and polyclonal antibody sequencing redefine the future of antibody discovery

Artificial intelligence and polyclonal antibody sequencing redefine the future of antibody discovery

Current and future strategies for vaccinating against invasive pneumococcal disease

Current and future strategies for vaccinating against invasive pneumococcal disease

NCCN publishes new resource on options, benefits of care approaches for pediatric Hodgkin lymphoma

NCCN publishes new resource on options, benefits of care approaches for pediatric Hodgkin lymphoma

COVID-19 associated with increased risk of developing various autoimmune diseases and risk could be attenuated by vaccination

COVID-19 associated with increased risk of developing various autoimmune diseases and risk could be attenuated by vaccination

A hybrid approach to re-engineer a SARS-CoV-1 neutralizing antibody against SARS-CoV-2

A hybrid approach to re-engineer a SARS-CoV-1 neutralizing antibody against SARS-CoV-2

Regulation of cytotoxic T-cell differentiation and exhaustion by mTOR signaling

Regulation of cytotoxic T-cell differentiation and exhaustion by mTOR signaling

New method to assess the status of immune responses to specific antigens in detail

New method to assess the status of immune responses to specific antigens in detail

Databases, techniques for variant forecasting and early warning of emerging infectious diseases

Databases, techniques for variant forecasting and early warning of emerging infectious diseases

Study suggests antibodies triggered by COVID-19 mRNA vaccination may depend on prior infection history

Study suggests antibodies triggered by COVID-19 mRNA vaccination may depend on prior infection history

Potential of COVID-19 convalescent plasma for future monoclonal antibodies against severe SARS-CoV-2 inflammation

Potential of COVID-19 convalescent plasma for future monoclonal antibodies against severe SARS-CoV-2 inflammation

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.